Search

Displaying results 6191 - 6200 of 10000 in total
  1. Drug

    Sporisorium cruentum

    go.drugbank.com/drugs/DB10873
    Approved

    Sporisorium cruentum is a fungus which can provoke allergic reactions. Sporisorium cruentum extract is used in allergenic testing.

  2. Drug

    Trichophyton rubrum

    go.drugbank.com/drugs/DB10915
    Approved

    Trichophyton rubrum is a fungus which can provoke allergic reactions. Trichophyton rubrum extract is used in allergenic testing.

  3. Drug

    Cochliobolus lunatus

    go.drugbank.com/drugs/DB10933
    Approved

    Cochliobolus lunatus is a fungus which can provoke allergic reactions. Cochliobolus lunatus extract is used in allergenic testing.

  4. Drug

    Haematonectria haematococca

    go.drugbank.com/drugs/DB10934
    Approved

    Haematonectria haematococca is a fungus which can provoke allergic reactions. Haematonectria haematococca extract is used in allergenic testing.

  5. Drug

    Neurospora sitophila

    go.drugbank.com/drugs/DB10969
    Approved

    Neurospora sitophila is a fungus which can provoke allergic reactions. Neurospora sitophila extract is used in allergenic testing.

    Mixtures: Rinkel Mold Mix A
  6. Drug

    Nordazepam

    go.drugbank.com/drugs/DB14028
    Investigational

    An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.

    Synonyms: N-desmethyldiazepam
  7. Drug

    Hyaluronic acid (non-animal stabilized)

    go.drugbank.com/drugs/DB19175
    ApprovedWithdrawn

    Hyaluronic acid (non-animal stabilized) is under investigation in clinical trial NCT03460158 (Prospective Evaluation of Facial Cosmetic Procedures).

  8. Drug

    Pentafluoropropane

    go.drugbank.com/drugs/DB13117
    ApprovedWithdrawn

    Pentafluoropropane is under investigation in clinical trial NCT01673061 (Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage).

  9. Drug

    GC012F

    go.drugbank.com/drugs/DB22406
    Investigational

    GC012F is under investigation in clinical trial NCT06419166 (An Exploratory Clinical Study of GC012F Injection for Refractory gMG).

  10. Drug

    Denibulin

    go.drugbank.com/drugs/DB05932
    Experimental

    Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.